This paper is in the following e-collection/theme issue:

Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1952) Public (e)Health, Digital Epidemiology and Public Health Informatics (1071) Recruitment of Research Participants (388) Smoking Cessation (645) Cancer Epidemiology, Cancer Surveillance and Infodemiology (126) Lung Cancer (72)

Published on in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/80281, first published .
Leveraging Social Media to Achieve Population-Level Reach of Lung Cancer Screening–Eligible Individuals: RE-AIM Framework–Based Secondary Analysis of a Randomized Controlled Trial

Leveraging Social Media to Achieve Population-Level Reach of Lung Cancer Screening–Eligible Individuals: RE-AIM Framework–Based Secondary Analysis of a Randomized Controlled Trial

Leveraging Social Media to Achieve Population-Level Reach of Lung Cancer Screening–Eligible Individuals: RE-AIM Framework–Based Secondary Analysis of a Randomized Controlled Trial

Authors of this article:

Lisa Carter-Bawa1, 2 Author Orcid Image ;   Jamie S Ostroff3 Author Orcid Image ;   Susan M Rawl4 Author Orcid Image ;   Erin A Hirsch1 Author Orcid Image ;   Smita C Banerjee3 Author Orcid Image ;   Andrew Ciupek5 Author Orcid Image ;   Robert Skipworth Comer6 Author Orcid Image ;   Minal Kale7 Author Orcid Image ;   Katherine T Leopold8 Author Orcid Image ;   Patrick O Monahan9 Author Orcid Image ;   James E Slaven Jr9 Author Orcid Image ;   Francis Valenzona1 Author Orcid Image ;   Renda Soylemez Wiener10, 11, 12 Author Orcid Image ;   Ana Guadalupe Vielma1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Lisa Carter-Bawa   1, 2 , MSN, MPH, PhD ;   Jamie S Ostroff   3 , PhD ;   Susan M Rawl   4 , PhD ;   Erin A Hirsch   1 , PhD ;   Smita C Banerjee   3 , PhD ;   Andrew Ciupek   5 , PhD ;   Robert Skipworth Comer   6 , MS ;   Minal Kale   7 , MPH, MD ;   Katherine T Leopold   8 , MD ;   Patrick O Monahan   9 , PhD ;   James E Slaven Jr   9 , MS ;   Francis Valenzona   1 , BS ;   Renda Soylemez Wiener   10, 11, 12 , MPH, MD ;   Ana Guadalupe Vielma   1 , PhD

1 Cancer Prevention Precision Control Institute, Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ, United States

2 Cancer Prevention & Control Program, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, United States

3 Department of Psychiatry & Behavioral Science, Memorial Sloan Kettering Cancer Center, New York, NY, United States

4 School of Nursing, Indiana University, Indianapolis, United States

5 Go2 for Lung Cancer, Washington, United States

6 School of Informatics, Indiana University, Indianapolis, United States

7 Department of Medicine, Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, United States

8 Hackensack Meridian School of Medicine, Hackensack Meridian Health, Nutley, United States

9 Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, IN, United States

10 Center for Health Optimization & Implementation Research, VA Boston Healthcare System, Boston, MA, United States

11 National Center for Lung Cancer Screening, Veterans Health Administration, Washington, DC, United States

12 The Pulmonary Center, Boston University Chobanian & Avedesian School of Medicine, Boston, MA, United States

Corresponding Author:

  • Lisa Carter-Bawa, MSN, MPH, PhD
  • Cancer Prevention Precision Control Institute, Center for Discovery & Innovation, Hackensack Meridian Health
  • 123 Metro Blvd, 6th Floor, 6400 Pod
  • Nutley, NJ 07110
  • United States
  • Phone: 1 646-246-2118
  • Email: lisa.carterbawa@hmh-cdi.org